Raphael Pharmaceutical RAPH Growth Metrics (2020-2026)

OTC RAPH
$1.51 +0.00 (+0.00%)
At close: Nov 6, 2026 · 4:00 PM EST
Reported Financials

Raphael Pharmaceutical Quarterly Growth Metrics

Periods 23 quarters
Latest Jun 2026

Raphael Pharmaceutical reported asset growth of -61.11% for the quarter ended Jun 2026. These growth metrics cover 23 quarters of results from Dec 2020 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Growth MetricsGrowth Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Growth Ratios
Total Debt (QoQ)
2.56%-5.00%-2.63%-29.73%400.00%426.15%-40.50%38.57%33.87%155.10%16.25%18.94%
Total Debt Growth (5y)
40.09%
Total Debt Growth (3y)
-52.61%762.67%308.73%
Total Debt Growth (1y)
1,166.67%-33.33%225.00%1,700.00%1,000.00%2,069.23%480.77%181.58%372.16%
Share-based Compensation (QoQ)Stock Comp. (QoQ)
-33.33%-31.83%-95.94%387.50%-97.44%
Share-based Compensation Growth (3y)Stock Comp. Growth (3y)
-68.09%-89.23%
Share-based Compensation Growth (1y)Stock Comp. Growth (1y)
-99.65%
Return on Equity [ROE] (QoQ)ROE (QoQ)
-10.49M10.74M-0.03M-0.84M-0.51M0.81M-7.01M
Return on Equity [ROE] Growth (1y)ROE Growth (1y)
-0.61M9.37M-0.57M0.72M-7.10M
Return on Capital Employed [ROCE] (QoQ)ROCE (QoQ)
-0.09M
Return on Capital Employed [ROCE] Growth (1y)ROCE Growth (1y)
-0.34M
Return on Assets [ROA] (QoQ)ROA (QoQ)
0.02M-0.04M-0.08M0.03M0.01M-0.10M0.14M0.06M-0.01M-0.01M-0.05M-0.28M0.16M-0.01M-1.84M
Return on Assets [ROA] Growth (3y)ROA Growth (3y)
-0.32M-0.11M-0.17M
Return on Assets [ROA] Growth (1y)ROA Growth (1y)
-0.08M-0.09M-0.14M0.08M0.11M0.09M0.18M-0.01M-0.35M-0.15M-0.20M
Property, Plant & Equipment (Net) (QoQ)PP&E (Net) (QoQ)
0.00%0.00%0.00%0.00%0.00%0.00%-50.00%
Property, Plant & Equipment (Net) Growth (1y)PP&E (Net) Growth (1y)
0.00%0.00%0.00%-50.00%
Operating Income (QoQ)Op. Inc (QoQ)
-8.57%-37.32%69.51%-249.71%-133.01%22.58%76.63%-62.40%-73.99%118.38%-508.21%54.48%-28.11%-23.51%-7.87%25.88%10.76%
Operating Income Growth (5y)Op. Inc Growth (5y)
12.36%
Operating Income Growth (3y)Op. Inc Growth (3y)
-45.84%37.34%-29.48%13.52%8.62%11.79%19.86%21.98%
Operating Income Growth (1y)Op. Inc Growth (1y)
-77.87%-152.86%30.56%-58.96%-241.15%-92.33%-47.43%31.54%48.88%112.14%-112.02%40.57%56.24%-394.03%-26.51%36.83%
Net Income towards Common Stockholders (QoQ)Net Income (QoQ)
-7.49%-36.30%67.37%-238.92%-130.14%23.56%76.07%-57.95%-73.86%116.83%-550.82%54.91%-31.45%-21.17%-8.61%24.94%2.62%
Net Income towards Common Stockholders Growth (5y)Net Income Growth (5y)
10.44%
Net Income towards Common Stockholders Growth (3y)Net Income Growth (3y)
-43.96%36.27%-29.20%13.79%7.80%11.35%-32.36%19.92%18.83%
Net Income towards Common Stockholders Growth (1y)Net Income Growth (1y)
-71.19%-146.52%27.45%-62.02%-246.88%-94.53%-42.70%33.49%49.76%111.06%-108.33%40.53%55.03%-423.77%22.00%-29.84%30.75%
Net Income (QoQ)
-7.49%-36.30%67.37%-238.92%-130.14%23.56%76.07%-57.95%-73.86%108.55%-987.10%54.91%-31.45%-21.17%-8.61%24.94%20.81%-7.06%16.12%2.62%
Net Income Growth (5y)
-0.97%-3.49%10.44%
Net Income Growth (3y)
-43.96%31.42%-29.20%13.79%7.80%11.35%-32.36%19.92%43.88%37.21%18.83%
Net Income Growth (1y)
-71.19%-146.52%27.45%-62.02%-246.88%-94.53%-42.70%33.49%49.76%105.62%-108.33%40.53%55.03%-737.10%22.00%-29.84%21.78%30.89%30.75%
Net Cash Flow (QoQ)NCF (QoQ)
-187.02%164.09%-162.07%175.00%-174.07%587.50%-228.21%129.20%157.53%-136.70%182.61%-394.74%52.38%73.75%247.62%-196.77%43.33%347.06%-204.76%
Net Cash Flow Growth (5y)NCF Growth (5y)
-6.57%12.34%
Net Cash Flow Growth (3y)NCF Growth (3y)
-46.89%38.74%-41.07%23.83%-29.68%34.45%-36.72%24.82%-40.06%43.96%
Net Cash Flow Growth (1y)NCF Growth (1y)
96.61%15.29%-74.04%77.90%68.10%-247.22%35.19%570.00%-135.38%122.80%-330.14%-142.55%69.57%-45.61%82.14%78.75%300.00%-241.94%
Income After Tax (QoQ)
-8.57%-37.32%69.51%-249.71%-133.01%22.58%76.63%-62.40%-73.99%118.38%-508.21%54.48%-28.11%-23.51%-7.87%25.88%10.76%
Income After Tax Growth (5y)
12.36%
Income After Tax Growth (3y)
-45.84%37.34%-29.48%13.52%8.62%11.79%19.86%21.98%
Income After Tax Growth (1y)
-77.87%-152.86%30.56%-58.96%-241.15%-92.33%-47.43%31.54%48.88%112.14%-112.02%40.57%56.24%-394.03%-26.51%36.83%
Free Cash Flow (QoQ)FCF (QoQ)
7.87%-150.53%88.35%-202.44%38.71%-82.24%-44.04%46.12%-133.02%82.44%-96.59%-26.01%63.30%22.50%-237.10%85.65%43.33%370.59%-195.65%
Free Cash Flow Growth (5y)FCF Growth (5y)
15.98%19.36%
Free Cash Flow Growth (3y)FCF Growth (3y)
42.71%-10.28%10.59%34.21%55.51%-36.60%50.54%51.82%29.39%52.05%
Free Cash Flow Growth (1y)FCF Growth (1y)
-50.43%36.43%18.69%45.91%60.65%-386.59%13.31%-229.61%68.23%56.64%-1.40%84.03%29.55%-20.81%86.24%78.75%174.19%78.95%
EPS (Diluted) (QoQ)
4.18%-48.01%72.04%-223.73%-108.53%19.72%78.50%-56.53%-70.32%116.55%-504.82%55.05%-31.27%-21.34%-3.34%24.94%2.62%
EPS (Diluted) Growth (5y)
20.94%
EPS (Diluted) Growth (3y)
28.14%20.19%25.30%-15.48%29.05%24.70%
EPS (Diluted) Growth (1y)
-28.38%-179.39%-51.54%-16.52%43.66%53.98%109.49%-78.65%48.70%60.46%-389.84%26.01%-23.55%32.63%
EPS (Basic) (QoQ)
4.18%-48.01%72.04%-223.73%-108.53%19.72%78.50%-56.53%-70.32%116.55%-504.82%55.05%-31.27%-21.34%-3.34%24.94%2.62%
EPS (Basic) Growth (5y)
20.94%
EPS (Basic) Growth (3y)
-19.73%32.00%-3.10%28.14%20.19%25.30%-15.48%29.05%24.70%
EPS (Basic) Growth (1y)
-33.48%-108.73%47.35%-28.38%-179.39%-51.54%-16.52%43.66%53.98%109.49%-78.65%48.70%60.46%-389.84%26.01%-23.55%32.63%
EBT (QoQ)
-8.57%-37.32%69.51%-249.71%-133.01%22.58%76.63%-62.40%-73.99%118.38%-508.21%54.48%-28.11%-23.51%-7.87%25.88%10.76%
EBT Growth (5y)
12.36%
EBT Growth (3y)
-45.84%37.34%-29.48%13.52%8.62%11.79%19.86%21.98%
EBT Growth (1y)
-77.87%-152.86%30.56%-58.96%-241.15%-92.33%-47.43%31.54%48.88%112.14%-112.02%40.57%56.24%-394.03%-26.51%36.83%
EBIT (QoQ)
-8.57%-37.32%69.51%-249.71%-133.01%22.58%76.63%-62.40%-73.99%118.38%-508.21%54.48%-28.11%-23.51%-7.87%25.88%10.76%
EBIT Growth (5y)
12.36%
EBIT Growth (3y)
-45.84%37.34%-29.48%13.52%8.62%11.79%19.86%21.98%
EBIT Growth (1y)
-77.87%-152.86%30.56%-58.96%-241.15%-92.33%-47.43%31.54%48.88%112.14%-112.02%40.57%56.24%-394.03%-26.51%36.83%
Cash from Operations (QoQ)Cash from Ops. (QoQ)
7.87%-150.53%88.35%-202.44%38.71%-82.24%-44.04%46.12%-133.02%82.44%-95.45%-26.74%63.30%22.50%-237.10%85.65%43.33%370.59%-195.65%
Cash from Operations Growth (5y)Cash from Ops. Growth (5y)
15.98%19.36%
Cash from Operations Growth (3y)Cash from Ops. Growth (3y)
42.71%-10.06%10.59%34.21%55.51%-36.60%50.54%51.82%29.39%52.05%
Cash from Operations Growth (1y)Cash from Ops. Growth (1y)
-50.43%36.43%18.69%45.91%60.65%-386.59%13.31%-229.61%68.23%56.89%-1.40%84.03%29.55%-21.51%86.24%78.75%174.19%78.95%
Cash & Equivalents (QoQ)Cash & Equiv. (QoQ)
313.51%-47.06%66.67%-31.11%209.68%-86.81%192.11%169.37%-23.08%24.78%-58.19%-66.67%-52.50%163.16%-60.00%-85.00%1,400.00%-97.78%0.00%
Cash & Equivalents Growth (5y)Cash & Equiv. Growth (5y)
-39.16%-13.88%
Cash & Equivalents Growth (3y)Cash & Equiv. Growth (3y)
102.51%34.28%2.63%-50.11%-14.85%-47.09%-68.17%-46.14%-79.19%
Cash & Equivalents Growth (1y)Cash & Equiv. Growth (1y)
2.78%61.05%151.35%88.24%-53.09%-17.78%221.51%-20.14%655.26%8.11%-86.62%-91.74%-82.58%-83.33%-92.50%136.84%-95.00%
Assets (QoQ)
580.65%-57.35%8.89%-38.27%175.21%-54.95%-20.67%238.66%-40.69%47.70%-63.74%-60.16%-47.06%244.44%-67.74%-76.67%657.14%-94.34%133.33%
Assets Growth (5y)
-30.33%
Assets Growth (3y)
-9.55%-6.30%-60.00%-19.76%-46.51%-61.32%-45.81%-61.11%
Assets Growth (1y)
30.65%95.16%-21.09%-16.67%-39.29%233.06%-28.23%135.33%7.56%-87.34%-88.70%-73.65%-76.56%-86.27%96.30%-76.67%

Raphael Pharmaceutical Growth Metrics API

Pull Raphael Pharmaceutical's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=RAPH&statement=Growth&frequency=Quarter&period=all&api_key=YOUR_API_KEY